Jul 7, 2022, 12:01 by Bob Davis

The 2022 state legislative sessions have been some of the busiest in recent memory. To review what transpired and its implications for the field of addiction medicine, ASAM assembled a first-of-its-kind state legislative recap.

Jul 7, 2022, 08:15 by Bob Davis

On June 27th, ASAM joined a Coalition of Whole Health letter to Centers for Medicare & Medicaid Services (CMS).

Jun 30, 2022, 10:00 by Bob Davis

On June 30th, the House Appropriations Committee approved the fiscal year (FY) 2023 Labor, Health and Human Services, Education, and Related Agencies bill.

Jun 27, 2022, 10:27 by Bob Davis

On June 23rd, the Oregon Society of Addiction Medicine (ORSAM) sent a letter supporting Oregon’s 1115 waiver application for expanded Medicaid coverage in correctional settings. If approved, ORSAM emphasized the importance of ensuring that evidence-based addiction treatment is available in all correctional facilities throughout the state.

Jun 22, 2022, 18:30 by Bob Davis

The Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666) includes vital provisions to help increase access to evidence-based addiction treatment at a time of unprecedented need

Jun 14, 2022, 09:56 by Bob Davis

On June 6th, the Pennsylvania Society of Addiction Medicine (PSAM) sent a letter to state lawmakers in support of SB 926. This legislation would legalize the operation of syringe service programs (SSPs) statewide. Under current law, it is still illegal to open a SSP in most parts of Pennsylvania.

Jun 6, 2022, 04:00 by Bob Davis

Our organizations write to express our deep concerns about false and harmful attempts to link mental illness and gun violence. The horrific school shooting in Uvalde, Texas that killed 19 children and two adults on May 24th is just one in a long series of mass shootings throughout our country.

Jun 3, 2022, 08:32 by Bob Davis

ASAM joined a large coalition of public health, harm reduction, HIV, and hepatitis organizations in sending a letter urging Congress to appropriate $150 million in fiscal year 2023 towards the Centers for Disease Control and Prevention’s (CDC) Infectious Diseases and Opioid Epidemic Program.

May 18, 2022, 14:13 by Bob Davis

Inclusion of Provisions Reflected in the Medication Access and Training Expansion (MATE) Act (H.R. 2067) and the Mainstreaming Addiction Treatment (MAT) Act (H.R. 1384) will help expand and mainstream addiction medicine.

May 12, 2022, 14:59 by Bob Davis

On May 11th, the Louisiana Society of Addiction Medicine (LSAM) sent a letter to members of the House Committee on Health and Welfare in support of SB 268. This legislation would require opioid treatment programs (OTPs) to provide medication for opioid use disorder (MOUD) to pregnant women.

May 11, 2022, 17:00 by Bob Davis

On May 11th, ASAM and other stakeholders sent a letter to U.S. House Energy and Commerce Committee leadership praising Section 321 of the Restoring Hope for Mental Health and Well-Being Act of 2022

May 10, 2022, 12:00 by Bob Davis

On May 10th, ASAM sent a letter[KMC1] to leadership of the U.S. House Committee on Energy and Commerce on H.R. 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 (the “Act”), in advance of the Subcommittee on Health’s legislative mark-up session on May 11th.

May 10, 2022, 09:41 by Bob Davis

On May 9th, the Louisiana Society of Addiction Medicine (LSAM) sent a letter to members of the Senate Committee on Judiciary C expressing support for HB 212.

May 3, 2022, 12:54 by Bob Davis

ASAM advocates for the need for sufficient appropriations for education, training, and loan repayment opportunities to expand the nation’s addiction treatment workforce.

Apr 28, 2022, 15:30 by Bob Davis

COSAM cautions that allowing law enforcement unrestricted access to the PDMP could compromise privacy and decrease treatment involvement.

Apr 28, 2022, 10:00 by Bob Davis

On April 28th, the Food and Drug Administration issued proposed rules to prohibit menthol as a characterizing flavor in cigarettes and to prohibit all characterizing flavors in cigars, following through on its promise of one year ago.

Apr 26, 2022, 10:00 by Bob Davis

Amid the ongoing opioid public health emergency, questions abound over the best way to spend federal funds to improve patient outcomes in addiction care.

Apr 21, 2022, 21:40 by Bob Davis

Today, ASAM praised the Biden-Harris Administration for releasing its inaugural National Drug Control Strategy, a critical roadmap to help address America’s addiction and overdose crisis.

Apr 14, 2022, 13:30 by Bob Davis

On April 12th, the Colorado Society of Addiction Medicine (COSAM) sent a letter to members of the House Committee on the Judiciary opposing calls to reinstate felony penalties for possession of small amounts of controlled substances. Currently, the General Assembly is considering HB 22-1326, a sweeping piece of legislation to address the rise in fentanyl overdoses in Colorado.

Apr 13, 2022, 11:46 by Bob Davis

On April 8th, the Colorado Society of Addiction Medicine (COSAM) sent a letter to the sponsors of HB 22-1064, expressing support for their bipartisan and bicameral legislation to regulate synthetic nicotine. Specifically, this legislation would expand the statutory definition of tobacco products to include synthetic nicotine and prohibit the marketing and sale of all flavored nicotine products.